MedTrace Logo

Secondary Prevention of Problems in Health Status in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT00940355 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 303

Last updated 2010-01-20

No results posted yet for this study

Summary

The purpose of this study is to determine the effectiveness of an intervention conducted by a pulmonary nurse in patients with COPD.

The hypothesis is that in a sample of COPD patients with clinically relevant problems in health status (physiological functioning, symptoms, functional impairment and quality of life), a motivational intervention conducted by a pulmonary nurse will lead to patient-tailored treatment and an improved health status.

Conditions

Interventions

BEHAVIORAL

Intervention pulmonary nurse

The intervention is conducted by a pulmonary nurse, directed at increasing awareness of problems in health status, and increasing motivation to engage in additional treatment, and improving health status.

Sponsors & Collaborators

  • PICASSO: Partners in Care Solutions for COPD

    collaborator OTHER

  • Radboud University Medical Center

    lead OTHER

Principal Investigators

  • Leonie Daudey, MSc. · Radboud University Nijmegen Medical Center, department of Medical Psychology & department of Pulmonary Diseases

  • Jan Vercoulen, Dr. · Radboud University Nijmegen Medical Center, department of Medical Psychology & department of Pulmonary Diseases

  • Jan Vercoulen, Dr. · Radboud University NIjmegen Medical Center, Department of Medical Psychology & department of Pulmonary Diseases

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-09-30
Primary Completion
2009-10-31
Completion
2009-10-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00940355 on ClinicalTrials.gov